Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Another Revisional Strategy to Address Severe Late Complications After Previous Biliopancreatic Diversion for Obesity: Major Revision From Standard Biliopancreatic Diversion to Proximal Roux-en-Y Gastric Bypass

NCT01041456 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT01041456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01041456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Another Revisional Strategy to Address Severe Late Complications After Previous Biliopancreatic Diversion for Obesity: Major Revision From Standard Biliopancreatic Diversion to Proximal Roux-en-Y Gastric Bypass
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Completed
Start date
March 31, 2009
Completion date
October 31, 2009
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intestinal malabsorptive syndrome, metabolic and nutritional complications, metabolic bone disease, protein malnutrition